Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 4:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 1,098 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physiological Clear all

Conditions: Non-alcoholic Steatohepatitis (NASH), Endoscopic Sleeve Gastroplasty, Non-alcoholic Fatty Liver Disease (NAFLD), Endoscopic Ultrasound, Liver Function, Obesity, Liver Fibroses
Interventions: Insulin Resistance, Quality of Life Assessment, Liver Function Test, Radiologic features of NASH, Serologic features of NASH; Diagnostic Test · Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypoxia
Interventions: Pulse Oximeter; Device
Lead sponsor: Oxitone Medical Ltd.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Suicide, Depressive Disorder, Treatment-Resistant, Ketamine, Molecular Mechanisms of Pharmacological Action, Neurotransmitter Agents, Excitatory Amino Acid Agents, Physiological Effects of Drugs, Depressive Disorder, Major, Depressive Disorder, Depression, Mental Disorders, Mood Disorders, Behavioral Symptoms
Interventions: (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg), Placebo; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Premature Ejaculation
Interventions: IX-01 400 mg, Placebo, IX-01 800 mg, IX-01 1200 mg; Drug
Lead sponsor: Ixchelsis Limited; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 29
States / cities: Mobile, Alabama • Chandler, Arizona • Mesa, Arizona + 25 more

Conditions: Stress, Physiological, Ethanol Intoxication, Distress, Emotional
Interventions: Relevant Trier Social Stressor Test (TSST), Ethanol, Placebo Trier Social Stressor Test (TSST), Placebo Beverage, Irrelevant Trier Social Stressor Test (TSST); Behavioral · Drug
Lead sponsor: Texas Tech University; Other
Eligibility: 21 Years to 29 Years
Enrollment: 165 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Coronary Artery Disease, Ischemic Heart Disease
Interventions: Philips SyncVision system with Philips pressure wires, standard of care angiographically-guided PCI; Device · Procedure
Lead sponsor: Philips Clinical & Medical Affairs Global; Industry
Eligibility: 18 Years and older
Enrollment: 3,212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 40
States / cities: Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 35 more

Conditions: Vasomotor Rhinitis
Interventions: Cold-dry air provocation, Warm-moist air provocation; Other
Lead sponsor: Associated Scientists to Help Minimize Allergies; Other
Eligibility: 18 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Erectile Dysfunction, Sexual Dysfunction
Interventions: Placebo, Dapoxetine, PDE5I (phosphodiesterase-5 inhibitor); Drug
Lead sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 495 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 19
States / cities: Decatur, Alabama • Huntsville, Alabama • Englewood, Colorado + 16 more

Conditions: Post-Lung Transplantation Bronchiectasis
Interventions: POWERBreathe Plus®, Cardiopulmonary rehabilitation post lung transplant; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Breast Cancer Female, Sexual Dysfunction
Interventions: Educational video series; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Irritable Bowel Syndrome
Interventions: IBS Group, Healthy Control Group; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2025
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Villanova, Pennsylvania

Conditions: Endometriosis
Interventions: Placebo, OBE2109; Drug
Lead sponsor: ObsEva SA; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 328 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 71
States / cities: Chandler, Arizona • Scottsdale, Arizona • Arcadia, California + 59 more

Conditions: Parkinson Disease, Dystonia, Essential Tremor
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Physiological Stress
Interventions: Not listed
Lead sponsor: Texas State University; Other
Eligibility: 18 Years to 39 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: San Marcos, Texas

Conditions: Hemodynamic Monitoring
Interventions: Noninvasive Hemodynamic Monitoring System; Device
Lead sponsor: AcQumen Medical, Inc.; Industry
Eligibility: 2 Months to 95 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Riverside, Connecticut

Conditions: Stress, Physiological
Interventions: Mindfulness training; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: GERD
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Disorder Related to Lung Transplantation, Chronic Lung Allograft Dysfunction
Interventions: Pirfenidone Capsule, Placebo Capsule; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Dyspareunia
Interventions: Mollie device; Device
Lead sponsor: JSP Innovations; Other
Eligibility: 18 Years and older · Female only
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Decatur, Illinois

Conditions: CHF, Renal Disease, Hypertension
Interventions: Not listed
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 136 participants
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: San Diego, California

Conditions: Aging
Interventions: Super Beets, Super Beets Placebo; Dietary Supplement
Lead sponsor: Darren P Casey; Other
Eligibility: 18 Years to 85 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Erectile Dysfunction
Interventions: placebo, avanafil; Drug
Lead sponsor: VIVUS LLC; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 646 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 41
States / cities: Birmingham, Alabama • Homewood, Alabama • Tucson, Arizona + 33 more

Conditions: Erectile Dysfunction
Interventions: GID SVF-2; Device
Lead sponsor: GID BIO, Inc.; Industry
Eligibility: 18 Years to 65 Years · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Vaginismus, Dyspareunia
Interventions: Milli Vaginal Dilator; Device
Lead sponsor: Materna Medical; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Mountain View, California

Search by objective public record fields.

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)

Internalized Stress in Relation to Alcohol Consumption

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation

Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction

Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant

Sexual Health and Breast Cancer: Developing Appropriate Education for Women Going Through Treatment

Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel Syndrome

A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis

Clinical and Physiological Studies of Tremor Syndromes

Impact of Combined Stress on Biomarkers of Stress

Evaluation of the UltraTrac System as a Non-Invasive Monitor of Hemodynamic Parameters

Mindfulness Training for Head Start Parents

Correlates of GERD Symptom Severity

Studying the Treatment Effect of Pirfenidone in Chronic Lung Allograft Dysfunction (STOP-CLAD)

The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device

Validation of a Sensor for Non-Invasive Measurements

Dietary Nitrate and Physiological Aging

Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED

Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)

Prospective on Market Patient-reported Outcomes for Milli